Business Wire

SAUDI-ECONOMY-PLANNING

Share
Saudi’s Ministry of Economy and Planning joins forces with UpLink to address food insecurity in arid climates

Saudi Arabia’s Ministry of Economy and Planning (MEP) in collaboration with UpLink today launched an innovation challenge designed to crowdsource transformative solutions to enhance food security in countries impacted by low rainfall, drought, and desertification.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230119005599/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Saudi's Ministry of Economy and Planning and UpLink launch innovation challenge to enhance food security. (Photo: AETOSWire)

MEP and UpLink, the World Economic Forum’s (WEF) open innovation platform, made the announcement at the Forums’ 2023 Annual Meeting in Davos as part of Saudi Arabia’s efforts to develop innovative solutions to the world’s most critical challenges, through collaboration and cooperation.

The Food Ecosystems and Arid Climates Challenge is a global call for food entrepreneurs, start-ups, social ventures, and small-medium sized enterprises to submit solutions that incorporate low or high technologies. The winning cohort will be eligible to access CHF100,000 to scale and implement their venture in regions with arid climates, while enhancing their visibility and access to networking opportunities. This is the first of two challenges focused on food systems, with a second to be launched later in 2023 on climate-smart agriculture.

Announcing the challenge at a press conference, His Excellency Faisal F. Alibrahim, Minister of Economy and Planning for the Kingdom of Saudi Arabia, said: “Our world faces a wide range of major socioeconomic challenges, and food security is at the top of the list.

“The Kingdom of Saudi Arabia is fully committed to being a major innovation accelerator, and dedicating resources to empower and support entrepreneurs who are determined to tackle the challenge of food security, in this case in regions with arid climates.”

Around 828 million people today are hungry, while 2.3 billion are food insecure. Furthermore, 3.1 billion people globally cannot afford a healthy diet and it is estimated that 700 million will be displaced by drought by 2030.

The challenge aims to strengthen food security and improve the supply of healthy and nutritious foods in arid regions by supporting solutions with a strong socioeconomic, environmental and educational impact to strengthen local food value chains.

With the support of government-led initiatives such as the Food Ecosystems and Arid Climates Challenge, it brings us closer to meeting Sustainable Development Goal (SDG) 2, Zero Hunger by 2030.

To drive a whole-of-government approach that achieves the 17 SDGs, MEP established and leads the Sustainable Development Steering Committee, which coordinates government efforts across the 2030 SDG Agenda.

Since the establishment of the Sustainable Development Steering Committee (SDSC), a governance structure has been operationalized and chaired by His Excellency Faisal Alibrahim and includes 20 senior stakeholders from various government entities to oversee Saudi Arabia's SDG Agenda.

Saudi Arabia is participating in the Annual Meeting 2023 (AM23) of the World Economic Forum in Davos between 16-20 January to bridge global divides and facilitate near-term stability while driving multilateral reform and long-term transformation.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005599/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye